Back to Journals » Therapeutics and Clinical Risk Management » Volume 12

New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib

Total article views   Abstract views HTML views PDF downloads Totals
12,861 Dovepress* 10,838 1,021+ 1,303 11,859
PubMed Central* 0 1,002 320 1,002
Totals 10,838 2,023 1,623 12,861
*Since 5 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
18 0 0 1 8 9

View citations on PubMed Central and Google Scholar